期刊文献+

白细胞介素6与代谢综合征 被引量:7

Interleukin 6 and Metabolic Syndrome
下载PDF
导出
摘要 代谢综合征是以中心性肥胖、糖尿病或糖调节受损、高血压、血脂异常等为主要特征,以胰岛素抵抗为共同病理生理基础,以多种代谢疾病合并出现的严重威胁人类健康的临床综合征。近来有研究表明,炎性因子与代谢综合征关系密切,炎性因子中的白细胞介素6(IL-6)与肥胖、胰岛素抵抗相关,而且在糖尿病发生发展过程中起重要作用。 Metabolic syndrome is a kind of clinical syndrome with the main feature of centricity obesity, diabetes or damaged glucose regulation, hypertension, lipid abnormality, and the common pathophysiological basis of insulin resistance, which often occurre binded with its multiple types and threaten the health of people seriously. Recent studies showed inflammatory factors had close relation- ship with metabolic syndrome, among which the IL-6 is related to obesity and insulin resistance and olav an imoortant role in the genesis and development of diabetes.
作者 方芳 肖常青
出处 《医学综述》 2007年第24期1994-1996,共3页 Medical Recapitulate
关键词 白细胞介素6 代谢综合征 胰岛素抵抗 Interleukin 6 Metabolic syndrome Insulin resistance
  • 相关文献

参考文献19

  • 1Keller KB,Lemberg L. Obesity and the metabolic syndrome[J]. Am J Crit Care,2003,12(2) : 167-170.
  • 2Fernandez-Real JM, Broch M, Vendrell J, et al. Interleukin 6 gene polymorphism and insulin sensitivity [ J ]. Diabetes, 2000,49 ( 3 ) : 517-520.
  • 3Pickup JC, Chusney GD, Thomas SM, et al. Plasma interleukin 6, tumor necrosis factor alpha and blood cytokine production in type 2 diabetes [J]. Life Sci,2000,67(3):291-300.
  • 4Pickup JC, Crook MA. Is type 2 diabetes mellitus a disease of the innate immune system? [ J]. Diabetologia, 1998,41 (8) : 1241-1248.
  • 5Sandler S, Bendtzen K, Eizirik DL, et al.Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro[ J]. Endocrinology, 1990,126(2) : 1288-1294.
  • 6Klover P J, Zimmers TA, Koniaris LG, et al. Chronic exposure to interleukin 6 causes hepatic insulin resistance in mice[J]. Diabetes,2003, 52(11) :2784-2789.
  • 7Vongs A,Fong TM,Xu L, et al. Functional STAT 1 and 3 signaling by the leptin receptor (OB-R):reduced expression of the rat fatty leptin receptor in transfected cells [ J ]. Endocrinology, 1996, 137 ( 11 ) : 5178-5181.
  • 8Serm JJ, Klover PJ, Nowak IA, et al. Suppressor of cytokine signaling-3 (SOCS-3) a potential mediator of interleukin 6 dependent insulin resistance in hepatoeytes[ J]. J Biol Chem, 2003,278(16) : 13740-13746.
  • 9Rieusset J, Bouzakri K, Chevillotte E, et al. Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients[J]. Diabetes,2004,53(9):2232-2241.
  • 10Lagathu C, Bastard JP, Auclair M, et al. Chronic interleukin 6 (IL-6) treatment increased IL-6 secretion and induced insulin resitance in adipocyte; prevention by rosiglitazone [J]. Biochem Res Commun, 2003, 311 (2) :372-379.

二级参考文献5

  • 1BARZILAY J I,ABRAHAM L,HECKBERT S R,et al.The relation of markers of inflammation to the development of glucose disorders in the elderly:the cardiovascular health study[J].Diabetes,2001,50:2384-2389.
  • 2MULLER S,MARTIN S,KOENIG W,et al.Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors[J].Diabetologia,2002,45:805-812.
  • 3PRANDHAN A D,MANSON J E,RIFAI N,et al.C-Reactive Protein,Interleukin 6,and risk of developing type 2 diabetes mellitus[J].JAMA,2001,286:327-334.
  • 4PICKUP J C,CROOK M A.Is type 2 diabetes mellitus a disease of the innate immune system[J]?Diabetologia,1998,41:1241-1248.
  • 5PAUL M,RIDKER M D,NADER R,et al.Plasma Concentration of Interleukin-6 and the risk of future myocardial infarction among apparently healthy men[J].Circulation,2000,101:1767-1772.

共引文献6

同被引文献103

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部